ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1471

Healthy Lifestyle and Risk of Rheumatoid Arthritis in Women: A Prospective Cohort Study

Jill Hahn1, May Choi2, Susan Malspeis3, Emma Stevens4, Elizabeth Karlson4, Kazuki Yoshida5, Laura Kubzansky6, Jeffrey Sparks7 and Karen Costenbader8, 1Brigham and Womens' Hospital, Newton, MA, 2Brigham and Women's Hospital | Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 3Brigham and Women's Hospital, Boston, 4Brigham and Women's Hospital, Boston, MA, 5Brigham & Women's Hospital and Harvard Medical School, Boston, MA, 6Harvard T.H. Chan School of Public Health, Boston, MA, 7Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 8Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2020

Keywords: autoimmune diseases, health behaviors, longitudinal studies, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health II: Risk Factors & Outcomes (1467–1471)

Session Type: Abstract Session

Session Time: 4:00PM-4:50PM

Background/Purpose: Many potentially modifiable biobehavioral factors have been associated with the risk of developing rheumatoid arthritis (RA), but the benefit of adopting an overall healthy lifestyle has not yet been examined. We investigated whether a healthy lifestyle, defined by a healthy lifestyle index score (HLIS), was associated with the risk of developing RA, overall and for seropositive or seronegative subtypes. We hypothesized that an increasingly healthy lifestyle, as measured by the HLIS, would be associated with reduced risk of RA, and we aimed to estimate the population attributable risk of these behaviors for RA.

Methods: We analyzed female nurses in the Nurses’ Health Study (NHS) (1986-2016) and NHSII (1991-2017). Behavioral, demographic, and medical information were assessed on biennial questionnaires. Incident RA was confirmed by medical record review. We created a healthy lifestyle index score (HLIS), following previous work and using 5 established biobehavioral RA risk factors: smoking, alcohol consumption, BMI, physical activity, and diet. For each factor, we created a binary variable with the “healthy” categories: never smoking; moderate alcohol use (5-15g, or about one drink/day), normal body weight (BMI 18.5–24.9 kg/m2)); regular exercise (at least 19 MET-hours/week, equivalent to at least 30 minutes of brisk walking every day); and healthy diet (in the top 2/5ths of the Alternative Healthy Eating Index). These were summed to create a HLIS, ranging from 0-5. Cox proportional hazards models, adjusted for confounders, modeled associations between HLIS (as continuous or categorical variables) and incident RA, overall and by serostatus. We calculated the population attributable risk (PAR) to estimate the proportion of incident RA in this population that would be prevented if all participants had adopted 4 or 5 healthy lifestyle factors.

Results: Among 107,090 women (mean age 43.7 years), we identified 1,219 incident RA cases (776 seropositive and 443 seronegative) in 4,467,872 person-years of follow-up (mean 24.0 years/participant). Higher continuous HLIS score was associated with a lower risk of RA (HR 0.87, 95% CI 0.83-0.91 per unit increase) overall, as well as with a lower risk of both seropositive RA (HR 0.86, 95% CI 0.81-0.92) and seronegative RA (HR 0.88, 95% CI 0.81-0.96) (Table). Women with all 5 healthy lifestyle factors had the lowest risk of developing RA (HR 0.42, 95% CI 0.22-0.80) and seropositive RA (HR 0.25, 95% CI 0.09-0.69), compared to those with no healthy lifestyle factors. The PAR for adhering to 4 or 5 lifestyle factors was 35% for overall RA.

Conclusion: In this large prospective cohort with lengthy follow-up, women who had a larger number of healthy lifestyle biobehaviors had a corresponding lower risk of both seropositive and seronegative RA. A large proportion of RA risk reduction may be attributable to healthy lifestyle independent of other confounders.

Table. Hazard ratios (95% CIs)a for risk of incident RA according to continuous and categorical healthy lifestyle index score (HLIS) among women in Nurses’ Health Study (1986-2016) and Nurses’ Health Study II (1991-2017).


Disclosure: J. Hahn, None; M. Choi, None; S. Malspeis, None; E. Stevens, None; E. Karlson, None; K. Yoshida, OM1, 1, Corrona, 1; L. Kubzansky, None; J. Sparks, Optum, 1, Janssen, 1, Inova, 1, Gilead, 1, Amgen, 1, Bristol-Myers Squibb, 1, 2; K. Costenbader, Glaxo Smith Kline, 5, UpToDate, 7, Lupus Foundation of America, 6, Neutrolis Inc, 5.

To cite this abstract in AMA style:

Hahn J, Choi M, Malspeis S, Stevens E, Karlson E, Yoshida K, Kubzansky L, Sparks J, Costenbader K. Healthy Lifestyle and Risk of Rheumatoid Arthritis in Women: A Prospective Cohort Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/healthy-lifestyle-and-risk-of-rheumatoid-arthritis-in-women-a-prospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/healthy-lifestyle-and-risk-of-rheumatoid-arthritis-in-women-a-prospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology